The Know AML website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and Know AML cannot guarantee the accuracy of translated content. Know AML and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
What are the possible side effects of immune therapies for acute myeloid leukemia?
John F. DiPersio
April 7, 2022
During the ESH 3rd How to Diagnose and Treat Acute Leukaemias, Know AML spoke with John F. DiPersio, Washington University School of Medicine, St. Louis, US. We asked, What are the possible side effects of immune therapies for acute myeloid leukemia?
DiPersio begins by discussing the challenges of the targeted nature of immune therapies, including side effects like neurotoxicity. He goes on to discuss data concerning the lack of efficacy and clinical benefit, and explains the biology behind myeloid cell targeting. Finally, he outlines methods of overcoming these challenges, highlighting recently failed approaches such as proteomic methods.
You can find additional resources on the management of side effects via our interactive graphic page.
To what extent do you agree with the following statements?
Please rate between 1 and 5, with 1 being 'strongly disagree' and 5 being 'strongly agree'.
